Sponsored by Emisphere
Vitamin B12 deficiency is an extremely common condition. It is estimated that there are up to 48 million adults in the United States with B12 deficiency. Many of these people are misdiagnosed, undiagnosed or under-treated, yet the condition is totally preventable and if caught early the potentially severe effects can be negated.
With age, it can become harder to absorb vitamin B12. It can also happen if you have had weight loss surgery or another operation that removed part of your stomach, if you drink heavily, or if you’ve taken acid-reducing medications for an extended time.
You may also be more likely to develop vitamin B12 deficiency if you have:
- Atrophic gastritis, in which your stomach lining has thinned
- Pernicious anemia, which makes it hard for your body to absorb vitamin B12
- Conditions that affect your small intestine, such as Crohn’s disease, celiac disease, bacterial growth, or a parasite
- Immune system disorders, such as Graves’ disease or lupus
You can also get vitamin B12 deficiency if you follow a vegan diet (meaning you don’t eat any animal products, including meat, milk, cheese, and eggs) or you are a vegetarian who doesn’t eat enough eggs or dairy products to meet your vitamin B12 needs. Finally, you may be a healthy sports enthusiast who takes vitamin B12 as part of your exercise recovery regimen.
The mainstay of treatment for the last 60 years has been intermittent deep intra-muscular injections of vitamin B12. However, with the introduction of Eligen B12™ tablets there is a convenient once daily oral treatment, the size of pediatric aspirin, which can give comparable clinical results to monthly injections. Eligen B12™ is the only oral product that has two measurable biomarkers that clinicians can use to monitor its effectiveness. It is well known that serum B12 levels are not a good indication of cellular B12 activity. Many patients with clinical signs of B12 deficiency will have “normal” or high levels of circulating B12, yet when tested further are shown to have a cellular deficiency indicated by high levels of Methyl Malonic Acid (MMA) and/or Homocysteine. Eligen B12™ is the only oral B12 treatment that in a clinical trial has been shown to reduce MMA and Homocysteine levels as effectively as B12 injections.
Eligen B12™ utilizes a proprietary delivery technology to significantly improve the absorption of B12. By combining Vitamin B12 with a carrier, Salcaprozate Sodium, Eligen B12 is the first oral formulation that in a clinical trial has been shown to perform as well as a B12 injection in patients with a clinical B12 deficiency. Eligen B12™ does not require the normal conditions in the gastrointestinal tract for absorption of Vitamin B12. Hence, an acid environment in the stomach and the presence of intrinsic factor are not necessary for absorption of Vitamin B12 when taken as Eligen B12™. Superior and maximum concentrations of B12 in the bloodstream are achieved within 30 minutes of ingestion as compared with 7-8 hours for traditional oral over-the-counter preparations of Vitamin B12.
One Eligen B12™ tablet should be taken daily in a fasted state at least 1 hour before a meal with approximately 2 oz. of water. It may be best to simply take it at night when you brush your teeth before bed. Once B12 levels are normalized it is safe and effective to reduce to an alternate day dosing regimen to maintain healthy levels.